MLLT6 maintains PD-L1 expression and mediates tumor immune resistance.
Sreevalsan S, Döring M, Paszkowski-Rogacz M, Brux M, Blanck C, Meyer M, Momburg F, Buchholz F, Theis M.
Sreevalsan S, et al. Among authors: momburg f.
EMBO Rep. 2020 Dec 3;21(12):e50155. doi: 10.15252/embr.202050155. Epub 2020 Oct 15.
EMBO Rep. 2020.
PMID: 33063451
Free PMC article.